CEACAM5 and colorectal carcinoma: Pesta et al. discovered that nine miRNAs, including miR-92a-3p and miR-210-3p, displayed a higher sensitivity and lower specificity than CEA and CA 19-9 as biomarkers of CRC recurrence [46].